Hims & Hers Health (NYSE: HIMS) stock surged more than 18% in regular trading on Tuesday after several analysts raised
8 months ago
Shares of Hims & Hers Health (NYSE: HIMS) surged over 23% in intraday trading on Tuesday, following the announcement of
Shares of Hims & Hers Health (NYSE: HIMS) fell 9% on Thursday after Chief Operating Officer Melissa Baird sold $910,687
9 months ago
Hims & Hers Health (NYSE: HIMS) stock plummeted more than 18% in after-hours trading on Monday after the telehealth company
10 months ago
Shares of Hims & Hers Health (NYSE: HIMS) plunged 23% on Friday after the U.S. Food and Drug Administration (FDA)
11 months ago
Canaccord Genuity analyst Maria Ripps raised her price target for Hims & Hers Health (NYSE: HIMS) to $68.00, up from
Hims & Hers Health (NYSE: HIMS) stock surged about 20% on Wednesday following the announcement of its acquisition of Trybe
NEW YORK – On Wednesday, Hims & Hers Health (NYSE: HIMS), the U.S. telehealth company, said it will sell compounded
1 year ago
Hims & Hers Health (NYSE: HIMS) stock soared 28% in intraday trading Monday after the telehealth company announced the addition
2 years ago
